Review genetic reports, clinical notes and current treatment, confirm rare‑disease subtype, and assess time‑critical interventions with our medical advisors.
Medical rigorCoordinating life‑saving treatment so no child with a rare disease is left untreated.
Neuravex connects families, doctors, hospitals, pharma companies and global donors to unlock life‑saving therapies for children with rare diseases, beginning with spinal muscular atrophy (SMA).
Compassion, transparency, measurable impact. Neuravex is not a fundraising campaign — it is a coordinated system for rare‑disease access.
How Neuravex operates
From verified case to coordinated treatment pathway
We combine clinical review, hospital coordination, pharma engagement and fundraising strategy into one transparent process — designed so that families, doctors and donors can collaborate effectively.
Link the family’s treating physician with German or international experts and identify hospitals able to deliver advanced therapies in the child’s country.
Clinical networkEngage pharma compassionate‑use and access programs where available, and design a funding plan bridging institutional donors, CSR and public crowdfunding.
Access & fundingMonitor treatment milestones with the care team, document fund flows, and publish anonymized outcomes so the global community can see real impact per child.
TransparencyWho we serve
Families, clinicians, hospitals, donors and pharma — working as one team
Neuravex is designed to be a neutral, trusted coordination layer between all stakeholders involved in rare‑disease care.
Guidance in a complex, global system
We help families navigate diagnosis, treatment options and funding without replacing their treating doctor.
- Case review and explanation in clear language.
- Connection to specialists for second opinions.
- Structured plan for hospital admission and timelines.
- Support to build or optimize fundraising campaigns.
A structured partner, not noise
We minimize chaos by curating documentation, aligning expectations and coordinating with donors and pharma.
- Standardized case summaries and documentation packs.
- Secure channel for expert‑to‑expert discussions.
- Support engaging hospital boards on pro‑bono or reduced‑cost slots.
- Outcome tracking that respects clinical workflows.
Verified impact with clear traceability
We are building a rare‑disease impact pipeline where every contribution is linked to a specific child and outcome.
- Case‑level visibility on medical plans and funding gaps.
- Preference for direct payments to hospitals or authorized partners.
- Ethical collaboration with pharma compassionate‑use and access programs.
- Aggregated, anonymized data on outcomes to inform future policy.
Our foundation
Compassion, transparency, trust and measurable impact
Neuravex is built to be the first trusted name families think of when a child in India — or anywhere in the world — is diagnosed with a rare disease.
-
Compassion with clinical discipline
Every case is a human story, but we insist on rigorous medical verification and realistic treatment plans.
-
Radical transparency
Our aim is clear documentation of decisions, fund flows and outcomes; where possible, donations flow directly to hospitals or authorized providers — not individuals.
-
Professional credibility
We are building a network of clinicians, scientists and advisors in Germany and globally to ensure medical decisions meet international standards.
Starting with spinal muscular atrophy and expanding as our expert and donor network grows.
We intentionally start small: a handful of deeply supported children to prove the model before scaling.
When a child is diagnosed anywhere, “Contact Neuravex” should be one of the first responses.
Start with one child
Refer a child or explore partnership
Share a case or reach out as a clinician, hospital, donor or pharma partner. We will review each message individually and respond with next steps.